Skip to main content
OpenTrials
Completed

NCT Number: NCT06557824

Pulmonary Rehabilitation Combined With Speleotherapy in Children With Bronchial Asthma

The goal of this retrospective study is to learn about the effects of rehabilitation and treatment stays combined with speleotherapy in children with asthma. Medical records of 415 patients with this clinical diagnosis were analyzed and the main question was:

• Does speleotherapeutic intervention increase distance in 6-Minute Walk Test (6MWT) and influence spirometry parameters and fractional exhaled nitric oxide concentration (FeNO) in children with asthma?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma in Children Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

3 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Physical Education in Krakow

Krakow, 31-571, Poland

About this study

Background: Bronchial asthma is the leading cause of chronic disease and missed school days in children. The aim of the study was to evaluate pulmonary function and exercise tolerance in children with asthma who underwent speleotherapeutic intervention (STI) between January 2022 and October 2023 at Sanatorium Edel in Zlaté Hory.

Methods: Medical records of 415 patients with clinical diagnosis of bronchial asthma (J45.9, J45.0, J45, J45.8, J45.1) were analysed. The patients attended rehabilitation and treatment stays with a median length of 32 days combined with an average number of 15 speleotherapy sessions. The spirometry parameters, fractional exhaled nitric oxide concentration (FeNO), and 6-Minute Walk Test (6MWT) distance were measured before and after STI.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children with asthma who partcipated in speleotherapeutic intervention in Sanatorium Edel in Zlate Hory

Exclusion criteria

  • Patients with incomplete data

Treatment and study plan

speleotherapeutic intervention

Other

In the study, medical records of 415 Czech children diagnosed with bronchial asthma who took part in speleotherapeutic intervention between January 2022 and October 2023 were analysed.

Primary outcomes

  1. Forced expiratory flow in 1 second

    Time frame: January 2022 and October 2023

    Forced expiratory flow in 1 second, pp=percent predicted (FEV1 [pp]) to assess the pulmonary function in children with asthma before and after speleotherapeutic intervention.

  2. 6-Minute Walk Test (6MWT)

    Time frame: January 2022 and October 2023

    6-Minute Walk Test (6MWT) distance was measured to assess exercise tolerance in children with asthma before and after speleotherapeutic intervention.

  3. Peak expiratory flow (PEFR [pp])

    Time frame: January 2022 and October 2023

    Peak expiratory flow (PEFR [pp]) to assess the pulmonary function in children with asthma before and after speleotherapeutic intervention.

Secondary outcomes

  1. Fractional exhaled nitric oxide concentration (FeNO)

    Time frame: January 2022 and October 2023

    The fractional exhaled nitric oxide concentration (FeNO) was measured to recognize the presence of eosinophillic inflammation involving the bronchial tree in children with asthma before and after speleotherapeutic intervention.

Sponsors and collaborators

Lead sponsor

University School of Physical Education, Krakow, Poland

Other

Collaborators

  • Andrzej Frycz Modrzewski Krakow University
  • Health Resort "Wieliczka" Salt Mine
  • Sanatorium Edel

Registry information

Official study title

Efficacy of Pulmonary Rehabilitation Combined With Speleotherapy in Children With Bronchial Asthma: a Retrospective Study.

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Aug 16, 2024
Registry last updated
Aug 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.